Genomic Valley Biotech Share price and Fundamental Analysis

Genomic Valley Biotech Share Price

Genomic Valley Biotech share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Genomic Valley Biotech Market Cap

Market capitalization of Genomic Valley Biotech indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Genomic Valley Biotech is valued compared to its competitors.

Genomic Valley Biotech PE Ratio

Genomic Valley Biotech PE ratio helps investors understand what is the market value of each stock compared to Genomic Valley Biotech 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Genomic Valley Biotech PEG Ratio

The PEG ratio of Genomic Valley Biotech evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Genomic Valley Biotech ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Genomic Valley Biotech generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Genomic Valley Biotech ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Genomic Valley Biotech in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Genomic Valley Biotech Total Debt

Total debt of Genomic Valley Biotech shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Genomic Valley Biotech Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Genomic Valley Biotech compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Genomic Valley Biotech CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Genomic Valley Biotech over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Genomic Valley Biotech Technical Analysis

Technical analysis of Genomic Valley Biotech helps investors get an insight into when they can enter or exit the stock. Key components of Genomic Valley Biotech Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Genomic Valley Biotech shares often struggle to rise above due to selling pressure.

Genomic Valley Biotech Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Genomic Valley Biotech ’s financial health and profitability.

Genomic Valley Biotech Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Genomic Valley Biotech Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Genomic Valley Biotech Financials

The financials of Genomic Valley Biotech provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Genomic Valley Biotech Profit and Loss Statements

The profit and loss statement of Genomic Valley Biotech highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Genomic Valley Biotech .

Genomic Valley Biotech Balance Sheet

The balance sheet presents a snapshot of Genomic Valley Biotech ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Genomic Valley Biotech Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.